Rule 36 India Import in Saudi Arabia
How the rule 36 india import pathway operates in Saudi Arabia.
About Rule 36 India Import
India's personal-use import pathway under Rule 36 of D&C Rules.
How Rule 36 India Import works in Saudi Arabia
The Saudi Food and Drug Authority (SFDA) operates a Personal Import / Unregistered Medicine pathway for named patients, typically requiring physician justification and hospital ethics-committee review.
Patients in Saudi Arabia seeking access under Rule 36 India Import typically follow this flow: a licensed physician in Saudi Arabia issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Saudi Arabia
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 1 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.